Abalone Collagen Extracts Potentiate Stem Cell Properties of Human Epidermal Keratinocytes.


Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
20 Jul 2019
Historique:
received: 12 06 2019
revised: 11 07 2019
accepted: 18 07 2019
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 7 3 2020
Statut: epublish

Résumé

Stem cell activities in human tissues are critical for tissue integrity and function. Maintaining keratinocyte stem cells (KSCs) stemness helps sustain healthy skin by supporting keratinocyte renewal, involving the formation of epidermal barriers. In this study, abalone collagen (AC) extracts with molecular weights of 3 kDa (AC 1) and 300 kDa (AC 2) were compared to the epidermal growth factor (EGF) for their effects on cell proliferation, cell migration (wound healing), spheroid formation, and the expression level of stem cell markers on human keratinocytes (HaCaT cells). Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell proliferation was quantified by ATP and DNA content analysis and Sulforhodamine B (SRB) assays. Cell migration assay was determined using the scratch wound healing test. Spheroid formation was evaluated and the expression level of stem cell markers was investigated by western blot analysis. The results showed that AC 1 at the concentration of 100 µg/mL could stimulate HaCaT cell proliferation, migration, spheroid formation, and the expression level of stem cell markers (keratin 19, β-catenin, ALDH1A1) compared to the control. In conclusion, a smaller molecular weight of abalone collagen extract exhibits a better effect on keratinocytes proliferation, migration, and stemness, which could be a potential active ingredient in cosmeceutical products.

Identifiants

pubmed: 31330853
pii: md17070424
doi: 10.3390/md17070424
pmc: PMC6669461
pii:
doi:

Substances chimiques

Epidermal Growth Factor 62229-50-9
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Research and Researcher for Industries
ID : MSD60I0092

Références

Eur J Dermatol. 2000 Oct-Nov;10(7):505-10
pubmed: 11056418
J Agric Food Chem. 2001 Apr;49(4):1984-9
pubmed: 11308357
Adv Drug Deliv Rev. 2003 Nov 28;55(12):1531-46
pubmed: 14623400
Science. 2004 Mar 5;303(5663):1483-7
pubmed: 15001769
J Agric Food Chem. 2004 Dec 29;52(26):7842-5
pubmed: 15612765
J Cell Biol. 2008 Jan 28;180(2):273-84
pubmed: 18209104
Pediatr Res. 2008 May;63(5):492-6
pubmed: 18427293
Blood. 2009 Feb 19;113(8):1670-80
pubmed: 18971422
Cold Spring Harb Symp Quant Biol. 2008;73:503-12
pubmed: 19022747
Int J Cosmet Sci. 2009 Aug;31(4):271-7
pubmed: 19496838
Br J Cancer. 2009 Jul 21;101(2):320-6
pubmed: 19568234
PLoS One. 2009 Nov 16;4(11):e7841
pubmed: 19924227
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Bioresour Technol. 2010 May;101(10):3737-42
pubmed: 20116238
PLoS One. 2010 Apr 16;5(4):e10202
pubmed: 20419137
J Cell Physiol. 2010 Nov;225(2):310-5
pubmed: 20568222
Development. 2011 Mar;138(6):1045-55
pubmed: 21307097
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a004978
pubmed: 21421911
Eur Cell Mater. 2011 Oct 19;22:242-57; discussion 257
pubmed: 22012735
J Thorac Oncol. 2012 Aug;7(8):1235-45
pubmed: 22617249
Cold Spring Harb Perspect Biol. 2012 Jul 01;4(7):a008383
pubmed: 22751151
Genes Dev. 2012 Oct 1;26(19):2144-53
pubmed: 22972935
Trends Biotechnol. 2013 Feb;31(2):108-15
pubmed: 23336996
Tissue Eng Part B Rev. 2014 Oct;20(5):365-80
pubmed: 24168395
Acta Biomater. 2014 Feb;10(2):883-92
pubmed: 24184178
Adv Wound Care (New Rochelle). 2014 Mar 1;3(3):272-280
pubmed: 24669361
J Dtsch Dermatol Ges. 2015 Apr;13(4):302-6
pubmed: 25819237
BMC Res Notes. 2015 Feb 20;8:47
pubmed: 25884200
Ann Biomed Eng. 2015 Dec;43(12):2978-90
pubmed: 26066056
Crit Rev Food Sci Nutr. 2017 May 24;57(8):1742-1748
pubmed: 26114550
Carbohydr Polym. 2015 Nov 5;132:606-19
pubmed: 26256388
Food Chem. 2012 May 1;132(1):487-92
pubmed: 26434320
Stem Cells Int. 2016;2016:9176357
pubmed: 26649054
Oncotarget. 2016 Mar 8;7(10):11018-32
pubmed: 26783961
Int J Pharm. 2016 Mar 30;501(1-2):96-101
pubmed: 26828672
PLoS One. 2017 Jan 19;12(1):e0169731
pubmed: 28103327
Mar Drugs. 2017 Mar 30;15(4):null
pubmed: 28358307
Dev Biol. 2017 Aug 15;428(2):273-282
pubmed: 28526587
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:787-795
pubmed: 28576050
Clin Plast Surg. 2017 Jul;44(3):635-650
pubmed: 28576253
Adv Wound Care (New Rochelle). 2017 Sep 1;6(9):297-307
pubmed: 28894637
J Cosmet Dermatol. 2018 Feb;17(1):20-26
pubmed: 29144022
Mediators Inflamm. 2017;2017:5217967
pubmed: 29213192
Biochem Biophys Res Commun. 2018 May 5;499(2):389-395
pubmed: 29580988
Heliyon. 2018 Sep 26;4(9):e00821
pubmed: 30272033
Cell Signal. 2019 Jan;53:256-268
pubmed: 30287279
Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:76-85
pubmed: 30423762
Mar Drugs. 2018 Nov 23;16(12):null
pubmed: 30477144
Mar Drugs. 2019 May 01;17(5):null
pubmed: 31052462
Toxicol In Vitro. 2019 Jun 11;60:252-260
pubmed: 31195088
J Cell Sci. 1996 May;109 ( Pt 5):1017-28
pubmed: 8743949
Genes Dev. 1997 Dec 15;11(24):3286-305
pubmed: 9407023
J Cell Sci. 1998 Nov;111 ( Pt 21):3179-88
pubmed: 9763512

Auteurs

Sajee Thaweekitphathanaphakdee (S)

College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand.

Pithi Chanvorachote (P)

Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Sagaw Prateepchinda (S)

Nation Nanotechnology Center, National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.

Mattaka Khongkow (M)

Nation Nanotechnology Center, National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.

Apirada Sucontphunt (A)

The Herbal Medicinal Products Research and Development Center, College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand. apirada@rsu.ac.th.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH